Jeffrey Robert Ajer - Mar 22, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 22, 2022
Transactions value $
-$669,143
Form type
4
Date filed
3/24/2022, 08:49 PM
Previous filing
Mar 17, 2022
Next filing
Mar 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$168K -2.07K -3.07% $81.00 65.4K Mar 22, 2022 Direct F1
transaction BMRN Common Stock Sale -$501K -6.13K -9.37% $81.78 59.3K Mar 23, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on February 28, 2022.